More Syntara Limited news Syntara LimitedASX: SNT LOX Inhibitor Program for Pancreatic Cancer Phase 1 Ready Nov 20, 2018 at 2:47 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
